← Leaderboards
Sarah C Heilshorn
Stanford University
$11,238,436
Attributed
$13,933,238
Total exposure
16
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,933,238 · 16
By mechanism
R01$8,677,507 · 7
DP2$2,400,000 · 1
R21$2,097,714 · 5
R61$433,092 · 1
R03$314,925 · 1
R13$10,000 · 1
Top collaborators
- Ngan F. Huang6 shared
- Giles Plant4 shared
- Helen M Blau2 shared
- David Myung2 shared
- Paul George1 shared
- Trevor J. Hastie1 shared
Most similar at Stanford University
Same institution · by research overlap
- Sergiu Pasca$19,655,599
- Fikri Birey$2,453,201
- Christopher N Ta$1,960,496
- Jan E Carette$15,833,982
- William T Newsome$5,320,890
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroBiocompatible MaterialsProteinsCellsDesignIn VivoTissuesCrosslinkPropertyHydrogelsMechanicsEncapsulatedBaseEngineeringPhenotypeSignal TransductionFamilyLigandsInjectableRegenerativeProtein EngineeringBiomechanicsRecombinantsPre-Clinical
Grant awards (37)
Catheter-injectable, engineered biomaterial for sustained Neuregulin-1 delivery to the myocardium$769,789
R01 · FY2025 · HL · contact PI
An Engineered Bioprinting Platform to Study Neural Migration in Assembloids$769,352
R01 · FY2025 · MH · contact PI
3D bioprinting of a bilayered, tissue engineered cornea$532,313
R01 · FY2025 · EY · contact PI
Tumor Metabolic Profiling by Multiplexed Single-Cell Lipid and mRNA Imaging$216,546
R61 · FY2025 · CA · contact PI
3D bioprinting of a bilayered, tissue engineered cornea$496,338
R01 · FY2024 · EY · contact PI
Tumor Metabolic Profiling by Multiplexed Single-Cell Lipid and mRNA Imaging$216,546
R61 · FY2024 · CA · contact PI
Injectable Hydrogels to Deliver Gene Therapy for Myocardial Infarct$396,347
R01 · FY2023 · HL · contact PI
Injectable Hydrogels to Deliver Gene Therapy for Myocardial Infarct$115,412
R01 · FY2023 · HL · contact PI
Injectable Hydrogels to Deliver Gene Therapy for Myocardial Infarct$28,965
R01 · FY2023 · HL · contact PI
Injectable Hydrogels to Deliver Gene Therapy for Myocardial Infarct$396,347
R01 · FY2022 · HL · contact PI
Injectable Hydrogels to Protect Transplanted Cells from Hypoxia$354,204
R01 · FY2022 · EB · contact PI
Engineered biomaterials to modulate cell-cell signaling for the robust expansion of stem cells$352,125
R01 · FY2022 · EB · contact PI
Imaging the metabolic and phagocytic landscape of microglia in Alzheimerâs disease$157,400
R03 · FY2022 · AG · contact PI
Injectable Hydrogels to Deliver Gene Therapy for Myocardial Infarct$396,347
R01 · FY2021 · HL · contact PI
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cells$392,872
R01 · FY2021 · HL
Injectable Hydrogels to Protect Transplanted Cells from Hypoxia$347,119
R01 · FY2021 · EB · contact PI
Engineered biomaterials to modulate cell-cell signaling for the robust expansion of stem cells$345,082
R01 · FY2021 · EB · contact PI
Imaging the metabolic and phagocytic landscape of microglia in Alzheimerâs disease$157,525
R03 · FY2021 · AG · contact PI
Combinatorial matrix-mimetic recombinant proteins as engineered nerve guidance conduits$436,238
R21 · FY2020 · NS · contact PI
Injectable Hydrogels to Deliver Gene Therapy for Myocardial Infarct$395,415
R01 · FY2020 · HL · contact PI
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cells$392,861
R01 · FY2020 · HL
Injectable Hydrogels to Protect Transplanted Cells from Hypoxia$354,204
R01 · FY2020 · EB · contact PI
Engineered biomaterials to modulate cell-cell signaling for the robust expansion of stem cells$352,125
R01 · FY2020 · EB · contact PI
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cells$392,500
R01 · FY2019 · HL
Injectable Hydrogels to Protect Transplanted Cells from Hypoxia$353,165
R01 · FY2019 · EB · contact PI
Engineered biomaterials to modulate cell-cell signaling for the robust expansion of stem cells$352,125
R01 · FY2019 · EB · contact PI
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cells$392,500
R01 · FY2018 · HL
Engineered Protein Hydrogels to Modulate Adipose-derived Stromal Cell Secretome and Exosomes for Injectable Myocardial Infarction Therapy$198,850
R21 · FY2018 · HL · contact PI
2018 Signal Transduction by Engineered Extracellular Matrices Gordon Research Conference and Gordon Research Seminar$10,000
R13 · FY2018 · EB · contact PI
Engineered Protein Hydrogels to Modulate Adipose-derived Stromal Cell Secretome and Exosomes for Injectable Myocardial Infarction Therapy$235,890
R21 · FY2017 · HL · contact PI
Injectable Hydrogels to Improve the Efficacy of iPSC-derived Therapies$189,350
R21 · FY2016 · EB · contact PI
Injectable Hydrogels to Improve the Efficacy of iPSC-derived Therapies$243,575
R21 · FY2015 · EB · contact PI
Engineered Intestinal Microenvironments as Preclinical Drug Screening Platforms$193,259
R21 · FY2015 · EB · contact PI
Engineered Intestinal Microenvironments as Preclinical Drug Screening Platforms$233,599
R21 · FY2014 · EB · contact PI
3D Bioengineering Strategies to Mimic Human Skeletal Muscle Progenitor Cell Niche$165,629
R21 · FY2012 · AR · contact PI
3D Bioengineering Strategies to Mimic Human Skeletal Muscle Progenitor Cell Niche$201,324
R21 · FY2011 · AR · contact PI
Engineering 3D in vitro niches to reveal fundamentals of cellular biomechanics$2,400,000
DP2 · FY2009 · OD · contact PI